المؤلفون: Yeoh, K., Lass-Flörl, C., Lamoth, F., Slavin, M.A., Williams, E., Neofytos, D.

المصدر: Transplant infectious disease, vol. 26, no. 4, pp. e14273

مصطلحات موضوعية: Humans, Middle Aged, Female, Leukemia, Myeloid, Acute/therapy, Acute/complications, Multiple Myeloma/therapy, Hematopoietic Stem Cell Transplantation/adverse effects, Transplantation, Homologous/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cytarabine/therapeutic use, Cytarabine/administration & dosage, Induction Chemotherapy, bloodstream infection, hematopoietic stem cell transplant, immunocompromised

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/38695847; info:eu-repo/semantics/altIdentifier/eissn/1399-3062; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6497609B679D1; https://serval.unil.ch/notice/serval:BIB_6497609B679D; https://serval.unil.ch/resource/serval:BIB_6497609B679D.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_6497609B679D
https://doi.org/10.1111/tid.14273
https://serval.unil.ch/resource/serval:BIB_6497609B679D.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6497609B679D1

المؤلفون: Russell, Nigel H., Wilhelm-Benartzi, Charlotte, Othman, Jad, Dillon, Richard, Knapper, Steven, Batten, Leona M., Canham, Joanna, Hinson, Emily L., Betteridge, Sophie, Overgaard, Ulrik Malthe, Gilkes, Amanda, Potter, Nicola, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Freeman, Sylvie D., Dennis, Mike

المصدر: Russell , N H , Wilhelm-Benartzi , C , Othman , J , Dillon , R , Knapper , S , Batten , L M , Canham , J , Hinson , E L , Betteridge , S , Overgaard , U M , Gilkes , A , Potter , N , Mehta , P , Kottaridis , P , Cavenagh , J , Hemmaway , C , Arnold , C , Freeman , S D , Dennis , M & UK NCRI AML Working Group 2024 , ' Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin ....

مصطلحات موضوعية: Adult, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Core Binding Factors, Cytarabine/therapeutic use, Gemtuzumab/therapeutic use, Granulocyte Colony-Stimulating Factor/therapeutic use, Humans, Idarubicin, Leukemia, Myeloid, Acute/drug therapy, Mutation, Neoplasm Recurrence, Local/drug therapy, Nuclear Proteins/genetics, Progression-Free Survival, Recurrence, Vidarabine/therapeutic use, fms-Like Tyrosine Kinase 3

الاتاحة: https://pure.au.dk/portal/en/publications/706f709d-396d-48d1-8214-6c91f7effa6f
https://doi.org/10.1200/JCO.23.00943
http://www.scopus.com/inward/record.url?scp=85188441493&partnerID=8YFLogxK

المؤلفون: Åbacka, Hannah, Hansen, Jesper S, Huang, Peng, Venskutonytė, Raminta, Hyrenius-Wittsten, Axel, Poli, Giulio, Tuccinardi, Tiziano, Granchi, Carlotta, Minutolo, Filippo, Hagström-Andersson, Anna K, Lindkvist-Petersson, Karin

المصدر: Haematologica EXODIAB: Excellence of Diabetes Research in Sweden. 106(4):1163-1166

مصطلحات موضوعية: Antimetabolites, Antineoplastic/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cytarabine/therapeutic use, Glucose Transporter Type 1/genetics, Humans, Leukemia, Myeloid, Acute/drug therapy, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology

URL الوصول: https://lup.lub.lu.se/record/b5b85024-a3ea-4938-8a62-7348f22a52bc
http://dx.doi.org/10.3324/haematol.2020.246843

المؤلفون: Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, Huls, Gerwin, EORTC Leukemia Group

المصدر: The Lancet Haematology, 10 (11), e879 - e889 (2023-11)

مصطلحات موضوعية: Decitabine, Cytarabine, Daunorubicin, Humans, Middle Aged, Aged, Decitabine/therapeutic use, Cytarabine/therapeutic use, Daunorubicin/therapeutic use, Transplantation, Homologous, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Leukemia, Myeloid, Acute/drug therapy, Leukemia, Myeloid, Acute/diagnosis, Hematology, Human health sciences, Sciences de la santé humaine, Hématologie

Relation: https://api.elsevier.com/content/article/PII:S2352302623002739?httpAccept=text/xml; urn:issn:2352-3026

URL الوصول: https://orbi.uliege.be/handle/2268/308889

المؤلفون: Chalandon, Yves, Rousselot, Philippe, Chevret, Sylvie, Cayuela, Jean-Michel, Kim, Rathana, Huguet, Françoise, Chevallier, Patrice, Graux, Carlos, Thiebaut-Bertrand, Anne, Chantepie, Sylvain, Thomas, Xavier, Vincent, Laure, Berthon, Céline, Hicheri, Yosr, Raffoux, Emmanuel, Escoffre-Barbe, Martine, Plantier, Isabelle, Joris, Magalie, Turlure, Pascal, Pasquier, Florence, Belhabri, Amine, Guepin, Gabrielle Roth, Blum, Sabine, Gregor, Michael, Lafage-Pochitaloff, Marina, Quessada, Julie, Lhéritier, Véronique, Clappier, Emmanuelle, Boissel, Nicolas, Dombret, Hervé

المصدر: ISSN: 0006-4971 ; Blood, vol. 143, no. 23 (2024) p. 2363-2372.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Humans, Cytarabine / administration & dosage, Cytarabine / therapeutic use, Female, Male, Adult, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Pyrimidines / therapeutic use, Pyrimidines / administration & dosage, Aged, Young Adult, Adolescent, Fusion Proteins, bcr-abl / genetics, Hematopoietic Stem Cell Transplantation

Relation: info:eu-repo/semantics/altIdentifier/pmid/38452207; info:eu-repo/semantics/dataset/url/https://clinicaltrials.gov/study/NCT02611492; https://archive-ouverte.unige.ch/unige:179723; unige:179723

الاتاحة: https://archive-ouverte.unige.ch/unige:179723

المؤلفون: Chalandon, Y., Rousselot, P., Chevret, S., Cayuela, J.M., Kim, R., Huguet, F., Chevallier, P., Graux, C., Thiebaut-Bertrand, A., Chantepie, S., Thomas, X., Vincent, L., Berthon, C., Hicheri, Y., Raffoux, E., Escoffre-Barbe, M., Plantier, I., Joris, M., Turlure, P., Pasquier, F., Belhabri, A., Guepin, G.R., Blum, S., Gregor, M., Lafage-Pochitaloff, M., Quessada, J., Lhéritier, V., Clappier, E., Boissel, N., Dombret, H.

المصدر: Blood, vol. 143, no. 23, pp. 2363-2372

مصطلحات موضوعية: Humans, Cytarabine/administration & dosage, Cytarabine/therapeutic use, Female, Male, Adult, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Pyrimidines/therapeutic use, Pyrimidines/administration & dosage, Aged, Young Adult, Adolescent, Fusion Proteins, bcr-abl/genetics, Hematopoietic Stem Cell Transplantation

Relation: info:eu-repo/semantics/altIdentifier/pmid/38452207; info:eu-repo/semantics/altIdentifier/eissn/1528-0020; https://serval.unil.ch/notice/serval:BIB_89C66CC22232

الاتاحة: https://serval.unil.ch/notice/serval:BIB_89C66CC22232
https://doi.org/10.1182/blood.2023023502

المؤلفون: Steinhardt, Maximilian Johannes, Krummenast, Franziska C., Rosenwald, Andreas, Gerhard-Hartmann, Elena, Heidemeier, Anke, Einsele, Hermann, Topp, Max S., Duell, Johannes

المصدر: http://lobid.org/resources/99370674181806441#!, 148(1):205-214.

مصطلحات موضوعية: HD, Lymphoma, Aged [MeSH], Prednisone/adverse effects [MeSH], Original Article – Clinical Oncology, Cytarabine/therapeutic use [MeSH], Progression-Free Survival [MeSH], Cyclophosphamide/therapeutic use [MeSH], Cyclophosphamide/adverse effects [MeSH], Rituximab/therapeutic use [MeSH], Male [MeSH], Central Nervous System Neoplasms/drug therapy [MeSH], Prednisone/therapeutic use [MeSH], Female [MeSH], Carmustine/therapeutic use [MeSH], Doxorubicin/adverse effects [MeSH], Large B-Cell, Diffuse/drug therapy [MeSH], Adult [MeSH], R-CHOP, Humans [MeSH], Hematopoietic Stem Cell Transplantation [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], MTX, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Vincristine/therapeutic use [MeSH], Methotrexate/therapeutic use [MeSH], Doxorubicin/therapeutic use [MeSH]

Relation: https://repository.publisso.de/resource/frl:6449866; https://doi.org/10.1007/s00432-021-03663-x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544/

الاتاحة: https://repository.publisso.de/resource/frl:6449866
https://doi.org/10.1007/s00432-021-03663-x
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544/

المؤلفون: Heuser, Michael, Smith, B. Douglas, Fiedler, Walter, Sekeres, Mikkael A., Montesinos, Pau, Leber, Brian, Merchant, Akil, Papayannidis, Cristina, Pérez-Simón, José A., Hoang, Caroline J., O’Brien, Thomas, Ma, Weidong Wendy, Zeremski, Mirjana, O’Connell, Ashleigh, Chan, Geoffrey, Cortes, Jorge E.

المصدر: http://lobid.org/resources/99370678538206441#!, 100(5):1181-1194.

مصطلحات موضوعية: Aged, 80 and over [MeSH], Phenylurea Compounds/therapeutic use [MeSH], Aged [MeSH], Cytarabine/therapeutic use [MeSH], Secondary acute myeloid leukemia, Antineoplastic Agents/administration, Original Article, Acute myeloid leukemia, Male [MeSH], Benzimidazoles/therapeutic use [MeSH], Benzimidazoles/administration, Female [MeSH], Neoplasms, Second Primary/drug therapy [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Survival Analysis [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Clinical trial, Antineoplastic Agents/therapeutic use [MeSH], Glasdegib, Leukemia, Myeloid, Acute/drug therapy [MeSH], Cytarabine/administration, Phenylurea Compounds/administration

Relation: https://repository.publisso.de/resource/frl:6447823; https://doi.org/10.1007/s00277-021-04465-4; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043884/

الاتاحة: https://repository.publisso.de/resource/frl:6447823
https://doi.org/10.1007/s00277-021-04465-4
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043884/

المؤلفون: Mühleck, Regina, Scholl, Sebastian, Hilgendorf, Inken, Schrenk, Karin, Hammersen, Jakob, Frietsch, Jochen J., Fleischmann, Maximilian, Sayer, Herbert G., Glaser, Anita, Hochhaus, Andreas, Schnetzke, Ulf

المصدر: http://lobid.org/resources/99370674181806441#!, 148(9):2539-2548.

مصطلحات موضوعية: Mito-FLAG, Refractory, Mitoxantrone/therapeutic use [MeSH], Original Article – Clinical Oncology, Salvage therapy, Cytarabine/therapeutic use [MeSH], Humans [MeSH], Vidarabine/therapeutic use [MeSH], Treatment Outcome [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Vidarabine/analogs, Granulocyte Colony-Stimulating Factor/therapeutic use [MeSH], Prognosis [MeSH], Remission Induction [MeSH], Leukemia, Myeloid, Acute/drug therapy [MeSH], Salvage Therapy/methods [MeSH], Relapse, AML

Relation: https://repository.publisso.de/resource/frl:6446900; https://doi.org/10.1007/s00432-021-03821-1; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349069/

الاتاحة: https://repository.publisso.de/resource/frl:6446900
https://doi.org/10.1007/s00432-021-03821-1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349069/

المؤلفون: Voigt, Margarete, Sinn, Konrad, Malouhi, Amer, Gecks, Thomas, Zinke, Jan, Hilgendorf, Inken, Scholl, Sebastian, Hochhaus, Andreas, Schnetzke, Ulf

المصدر: http://lobid.org/resources/99370678538206441#!, 100(7):1895-1897.

مصطلحات موضوعية: Herpesvirus 6, Human/isolation, Antimetabolites, Antineoplastic/therapeutic use [MeSH], Female [MeSH], Human/drug effects [MeSH], Adult [MeSH], Encephalitis, Viral/complications [MeSH], Cytarabine/therapeutic use [MeSH], Humans [MeSH], Acyclovir/therapeutic use [MeSH], Letter to the Editor, Oncology, Leukemia, Myeloid, Acute/complications [MeSH], Viral/pathology [MeSH], Hematology, Viral/drug therapy [MeSH], Antiviral Agents/therapeutic use [MeSH], Acute/drug therapy [MeSH], Acute/pathology [MeSH]

Relation: https://repository.publisso.de/resource/frl:6447843; https://doi.org/10.1007/s00277-021-04409-y; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195884/

الاتاحة: https://repository.publisso.de/resource/frl:6447843
https://doi.org/10.1007/s00277-021-04409-y
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195884/

المؤلفون: Shahswar, Rabia, Beutel, Gernot, Gabdoulline, Razif, Koenecke, Christian, Markel, Dominik, Eder, Matthias, Stadler, Michael, Gohring, Gudrun, Schlegelberger, Brigitte, Trummer, Arne, Krauter, Juergen, Thol, Felicitas, Heuser, Michael

المصدر: http://lobid.org/resources/99370678538206441#!, 100(2):595-599.

مصطلحات موضوعية: Bridged Bicyclo Compounds, Heterocyclic/adverse effects [MeSH], Female [MeSH], Antineoplastic Agents/adverse effects [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Heterocyclic/administration, Adult [MeSH], Cytarabine/therapeutic use [MeSH], Azacitidine/therapeutic use [MeSH], Humans [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Letter to the Editor, Oncology, Sulfonamides/administration, Decitabine/therapeutic use [MeSH], Hematology, Sulfonamides/adverse effects [MeSH], Male [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Leukemia, Myeloid, Acute/drug therapy [MeSH], Acute/physiopathology [MeSH], Tumor Lysis Syndrome/etiology [MeSH]

Relation: https://repository.publisso.de/resource/frl:6466988; https://doi.org/10.1007/s00277-020-04181-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/

الاتاحة: https://repository.publisso.de/resource/frl:6466988
https://doi.org/10.1007/s00277-020-04181-5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817590/

المؤلفون: Branco, Paola Cristina, Jimenez, Paula Christine, Machado-Neto, João Agostinho, Costa-Lotufo, Letícia Veras

المساهمون: Department of Pharmacology, Institute of Biomedical Sciences of the University of São Paulo, São Paulo, (PCB) (JAM-N) (LVC-L) Brazil, Department of Marine Sciences, Federal University of Sao Paulo, Santos, (PCJ), Brazil

مصطلحات موضوعية: BIRC5, Cell cycle progression, Apoptosis, Cancer, Genes Section, Adolescent, Adult, Age Factors, Burkitt Lymphoma/*genetics, Child, Preschool, Chromosome Aberrations, Chromosomes, Human/*genetics, Female, Humans, Infant, Loss of Heterozygosity, Male, Neoplasm Proteins/*genetics, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Burkitt Lymphoma/diagnosis/*drug therapy/genetics, Cyclophosphamide/therapeutic use, Cytarabine/therapeutic use, Doxorubicin/therapeutic use, Etoposide/therapeutic use

Relation: Atlas of Genetics and Cytogenetics in Oncology and Haematology; http://AtlasGeneticsOncology.org/Genes/BIRC5ID797ch17q25.html; Paola Cristina, Branco; Paula Christine, Jimenez; João Agostinho, Machado-Neto; Letícia Veras, Costa-Lotufo. BIRC5 (baculoviral IAP repeat containing 5). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2019, 07, p. 168-186; http://hdl.handle.net/2042/70468; https://doi.org/10.4267/2042/70468

الاتاحة: http://hdl.handle.net/2042/70468
https://doi.org/10.4267/2042/70468

المؤلفون: Anton Hagenbeek, Julia Driessen, Roberto D Liu, Marcel Nijland, Pauline Brice, Wouter J. Plattel, Roelf Valkema, Thomas Gastinne, Harm van Tinteren, Marie José Kersten, Martin Hutchings, Pieternella J. Lugtenburg, Sanne H. Tonino, Daphne de Jong, Arjan Diepstra, Josée M. Zijlstra, Franck Morschhauser, Marta Lopez-Yurda, Coreline N. Burggraaff, Anne I.J. Arens

المساهمون: Hematology, CCA - Cancer Treatment and quality of life, VU University medical center, Internal medicine, Pathology, Stem Cell Aging Leukemia and Lymphoma (SALL), Radiology & Nuclear Medicine, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Graduate School

المصدر: Haematologica, 106(4), 1129-1137. Ferrata Storti Foundation
Haematologica, 106, 1129-1129
Haematologica
Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238
Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION
Haematologica, 106, 4, pp. 1129-1129

مصطلحات موضوعية: Oncology, Immunoconjugates, medicine.medical_treatment, Salvage treatment, Salvage therapy, Cytarabine/therapeutic use, Gastroenterology, Dexamethasone, 0302 clinical medicine, Recurrence, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, Brentuximab vedotin, Hodgkin Disease/drug therapy, Brentuximab Vedotin, Cytarabine, Hematology, Hodgkin Disease, Treatment Outcome, Local, 030220 oncology & carcinogenesis, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, medicine.medical_specialty, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, High dose cytarabine, Internal medicine, DHAP, medicine, Refractory Hodgkin Lymphoma, Humans, Progression-free survival, Cisplatin, Salvage Therapy, Chemotherapy, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Comment, medicine.disease, Dexamethasone/therapeutic use, Neoplasm Recurrence, Neoplasm Recurrence, Local, business, Progressive disease, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2319065b3dca13fbddf9056a28a1f65f
https://research.rug.nl/en/publications/d7844e9e-fb58-46a6-90c3-61fa5f40a19c

المؤلفون: Keith W. Pratz, Panayiotis Panayiotidis, Christian Recher, Xudong Wei, Brian A. Jonas, Pau Montesinos, Vladimir Ivanov, Andre C. Schuh, Courtney D. DiNardo, Jan Novak, Vlatko Pejsa, Don Stevens, Su-Peng Yeh, Inho Kim, Mehmet Turgut, Nicola Fracchiolla, Kazuhito Yamamoto, Yishai Ofran, Andrew H. Wei, Cat N. Bui, Katy Benjamin, Rajesh Kamalakar, Jalaja Potluri, Wellington Mendes, Jacob Devine, Walter Fiedler

المصدر: Blood cancer journal, vol 12, iss 4
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: Myeloid, Leukemia, Myeloid, Acute / etiology, Cytarabine / therapeutic use, Oncology and Carcinogenesis, EUROPEAN-ORGANIZATION, RISK MYELODYSPLASTIC SYNDROME, Acute, Cardiorespiratory Medicine and Haematology, Bridged Bicyclo Compounds, Rare Diseases, QUALITY-OF-LIFE, Clinical Research, SUPPORTIVE CARE, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Humans, REPORTED OUTCOMES, ELDERLY-PATIENTS, Fatigue, Cancer, Sulfonamides, Leukemia, OLDER PATIENTS, Heterocyclic, Cytarabine, Hematology, RANDOMIZED PHASE-III, Bridged Bicyclo Compounds, Heterocyclic, CONTROLLED-TRIALS, LOW-DOSE CYTARABINE, Leukemia, Myeloid, Acute, Fatigue / etiology, Oncology, Quality of Life, Leukemia, Myeloid, Acute / drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcf3b9e9e68cdfa7fbed5e1e2969318
https://urn.nsk.hr/urn:nbn:hr:105:795165

المؤلفون: Barbara Tomic, Tomislav Smoljo, Hrvoje Lalic, Vilma Dembitz, Josip Batinic, Drago Batinic, Antonio Bedalov, Dora Visnjic

مصطلحات موضوعية: Multidisciplinary, Cytarabine / therapeutic use, Cytarabine, Dihydroorotate Dehydrogenase, Cell Differentiation, Enzyme Inhibitors / pharmacology, cytarabine, acute myeloid leukemia, differentiation, Chk1, brequinar, AICAr, DHODH, pyrimidine synthesis, Leukemia, Myeloid, Acute, Pyrimidines, Checkpoint Kinase 1, Cytarabine / pharmacology, Pyrimidines / therapeutic use, Checkpoint Kinase 1 / metabolism, Humans, Enzyme Inhibitors, Leukemia, Myeloid, Acute / genetics

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d328b03c9280a3fbd95f7362c438e671
https://www.bib.irb.hr/1211738

المساهمون: Yundeok Kim, Ju-In Eom, Hoi-Kyung Jeung, Ji Eun Jang, Jin Seok Kim, June-Won Cheong, Young Sam Kim, Yoo Hong Min, Kim, Young Sam, Kim, Yun Deok, Kim, Jin Seok, Min, Yoo Hong, Jang, Ji Eun, Cheong, June Won, Cheong, June-Won

مصطلحات موضوعية: Antimetabolites, Antineoplastic/pharmacology, Antineoplastic/therapeutic use, Autophagy/drug effects, Autophagy/physiology, Cell Death/drug effects, Cell Death/physiology, Cytarabine/pharmacology, Cytarabine/therapeutic use, Drug Resistance, Neoplasm/drug effects, Neoplasm/physiology, Humans, Hydroxychloroquine/pharmacology, Hydroxychloroquine/therapeutic use, Leukemia, Myeloid, Acute/drug therapy, Acute/pathology, U937 Cells, Acute myeloid leukemia, Apoptosis, Autophagy, Chemoresistance, Hydroxychloroquine

وصف الملف: 87~96

Relation: BIOMEDICINE & PHARMACOTHERAPY; J00322; OAK-2015-02103; https://ir.ymlib.yonsei.ac.kr/handle/22282913/141263; http://www.sciencedirect.com/science/article/pii/S0753332215001250; T201503724; BIOMEDICINE & PHARMACOTHERAPY, Vol.73 : 87-96, 2015

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/141263
https://doi.org/10.1016/j.biopha.2015.05.012
http://www.sciencedirect.com/science/article/pii/S0753332215001250

المساهمون: Yundeok Kim, Sulhee Yoon, Soo Jeong Kim, Jin Seok Kim, Jun-Won Cheong, Yoo Hong Min, Kim, Soo Jeong, Kim, Yun Deok, Kim, Jin Seok, Min, Yoo Hong, Yoon, Sul Hee, Cheong, June Won, Cheong, June-Won

المصدر: T201203448.pdf

مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Cytarabine/therapeutic use, Disease-Free Survival, Female, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Humans, Idarubicin/therapeutic use, Immunophenotyping, Leukemia, Myeloid, Acute/drug therapy, Acute/enzymology, Acute/mortality, Acute/therapy, Male, Middle Aged, Peroxidase/metabolism, Retrospective Studies, Young Adult, Myeloperoxidase, acute myeloid leukemia, prognostic factor, transplant

Relation: YONSEI MEDICAL JOURNAL; J02813; OAK-2012-01932; https://ir.ymlib.yonsei.ac.kr/handle/22282913/92142; T201203448; YONSEI MEDICAL JOURNAL, Vol.53(3) : 530-536, 2012

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/92142

المساهمون: Ho-Jin Shin, Hyeoung-Joon Kim, Sang Kyun Sohn, Yoo Hong Min, Jong-Ho Won, Inho Kim, Hwi-Joong Yoon, Jae Hoon Lee, Deog-Yeon Jo, Young Don Joo, Chul Won Jung, Kyoo-Hyung Lee, Min, Yoo Hong

المصدر: T201003390.pdf

مصطلحات موضوعية: Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cohort Studies, Core Binding Factors/metabolism, Cytarabine/administration & dosage, Cytarabine/therapeutic use, Daunorubicin/administration & dosage, Disease-Free Survival, Female, Humans, Leukemia, Myeloid, Acute/metabolism, Acute/mortality, Acute/therapy, Male, Middle Aged, Remission Induction, Stem Cell Transplantation, Survival Rate, Young Adult

وصف الملف: 556~566

Relation: JAPANESE JOURNAL OF CLINICAL ONCOLOGY; J01207; OAK-2010-01753; https://ir.ymlib.yonsei.ac.kr/handle/22282913/102153; T201003390; JAPANESE JOURNAL OF CLINICAL ONCOLOGY, Vol.40(6) : 556-566, 2010

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/102153
https://doi.org/10.1093/jjco/hyq007

المساهمون: Sung Jin Hong, Jin Seok Kim, Jong Hee Chang, Kyoung Min Kim, Soo Jeong Kim, Hye Won Lee, June-Won Cheong, Seung Tae Lee, Yoo Hong Min, Kim, Kyung Rae, Kim, Soo Jeong, Kim, Jin Seok, Min, Yoo Hong, Chang, Jong Hee, Cheong, June Won, Cheong, June-Won

المصدر: T200903228.pdf

مصطلحات موضوعية: Antibodies, Monoclonal/therapeutic use, Monoclonal, Murine-Derived, Central Nervous System Neoplasms/drug therapy, Central Nervous System Neoplasms/therapy, Cytarabine/therapeutic use, Etoposide/therapeutic use, Female, Humans, Ifosfamide/therapeutic use, Lymphoma, Non-Hodgkin/drug therapy, Non-Hodgkin/therapy, Middle Aged, Rituximab, Stem Cell Transplantation/methods, Primary central nervous system lymphoma, high-dose chemotherapy with autologous stem cell rescue, salvage therapy

وصف الملف: 280~283

Relation: YONSEI MEDICAL JOURNAL; J02813; OAK-2009-01456; https://ir.ymlib.yonsei.ac.kr/handle/22282913/104796; T200903228; YONSEI MEDICAL JOURNAL, Vol.50(2) : 280-283, 2009

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/104796
https://doi.org/10.3349/ymj.2009.50.2.280

المؤلفون: Vulliemoz, Serge, Lurati-Ruiz, F, Borruat, F-X, Delavelle, Jacqueline, Koralnik, I J, Kuntzer, Thierry, Bogousslavsky, J, Picard, Fabienne, Landis, Theodor, Du Pasquier, Renaud Alfred Robert

المصدر: ISSN: 0022-3050 ; Journal of neurology, neurosurgery and psychiatry, vol. 77, no. 9 (2006) p. 1079-1082.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616.0757, info:eu-repo/classification/ddc/616.8, Adrenergic alpha-Antagonists / therapeutic use, Cytarabine / therapeutic use, Dermatomyositis / complications, Female, Humans, Immunosuppressive Agents / therapeutic use, Leukoencephalopathy, Progressive Multifocal / drug therapy, Progressive Multifocal / etiology, Male, Mianserin / analogs & derivatives, Mianserin / therapeutic use, Middle Aged, Mirtazapine, Treatment Outcome

Relation: info:eu-repo/semantics/altIdentifier/pmid/16914758; https://archive-ouverte.unige.ch/unige:156497; unige:156497

الاتاحة: https://archive-ouverte.unige.ch/unige:156497